New Suboxone Clinic In Eastern Washington State

There's a new Sub Clinic in Tri Cities, WA. Opening early July 2012. in Kennewick, WA.

Name: Ideal Option Suboxone Clinic
Address: 415 North Morain Street, Suite B Tri Cities, WA 99336
Phone number: 509-222-1275

Hope this helps!

REPLY

REPORT

1 Reply

Hi Sub,

Thanks for that information. I'll add some additional information regarding Suboxone for anyone who is curious:

Suboxone (Buprenorphine) is a semi-synthetic opioid that is used to treat opioid addiction in higher dosages (>2mg), to control moderate acute pain in non-opioid-tolerant individuals in lower dosages, and to control moderate chronic pain. It is available in a variety of formulations: Subutex, Suboxone (Buprenorphine HCl and naloxone HCl; typically used for opioid addiction), Temgesic (sublingual tablets for moderate to severe pain), Buprenex (solutions for injection often used for acute pain in primary-care settings), Norspan and Butrans (transdermal preparations used for chronic pain). Subutex and Suboxone are available in 2mg and 8mg sublingual dosages. (Suboxone Film is also available in doses of 4mg/1mg & 12mg/3mg buprenorphine/naloxone respectively).

Indications:

Depending on the application form, buprenorphine is indicated for the palliation of moderate to severe acute or chronic pain with no neuralgic component (or when the neuralgia is otherwise treated, such as with pregabalin), or for peri-operative analgesia. For the treatment of chronic pain, the transdermal formulations (which were released in the United States in January 2011, but were available in Australia and many European countries years beforehand) are preferred. The intravenous formulation is mainly used in postoperative pain (for example, as patient controlled analgesia [PCA]).

Sublingual buprenorphine (also sometimes taken buccally) for pain is available in the United Kingdom, as well as the Republic of India, in dosages of 200 and 400µg. It is not available in the United States or in Canada, although Subutex or Suboxone (sublingual buprenorphine for addiction) is sometimes used off-label for this purpose, up to a dosage of 2 mg (the lowest-strength Subutex/Suboxone tablet). Sublingual formulations, such as Addnok, Temgesic, Subutex, and Suboxone, are us ed either as breakthrough medication for patients on transdermal treatment, or as monotherapy in cases where other treatments are not suitable.

Adverse effects:

The most severe and serious adverse reaction associated with opioid use in general is respiratory depression, the mechanism behind fatal overdose. Buprenorphine behaves differently than other opioids in this respect, as it shows a ceiling effect for respiratory depression. Moreover, former doubts on the antagonisation of the respiratory effects by naloxone have been disproved: Buprenorphine effects can be antagonised with a continuous infusion of naloxone. Concurrent use of buprenorphine and CNS depressants (such as alcohol or benzodiazepines) is not recommended as it may lead to fatal respiratory depression. Benzodiazepines, in prescribed doses, are not contraindicated in individuals tolerant to either opioids or benzodiazepines.

People on medium- to long-term maintenance with Suboxone or Subutex do not have a risk of overdose from buprenorphine alone, no matter what dosage is taken or route of administration it is taken by, due to the "ceiling effect" on respiratory depression. Overdoses occurring in maintenance patients are cases of multiple-drug intoxication, usually buprenorphine taken with excessive amounts of ethanol and/or benzodiazepine drugs. As a matter of course, all patients on buprenorphine maintenance are tolerant to opioids, and maintenance doses are always higher than the dose at which the "ceiling effect" on respiratory depression is reached (~3±1 milligrammes, depending on method of analysis).

People switching from other opiates should wait until mild to moderate withdrawal symptoms are encountered. Failure to do so can lead to the rapid onset of intense withdrawal symptoms, known as precipitated withdrawal.[49] For short acting opioids such as codeine, hydrocodone, oxycodone, hydromorphone, pethidine, heroin, and morphine, 12"24 hours from the last dose is generally sufficient. For longer acting opioids such as methadone, 2"3 days from the last dose is needed to prevent precipitated withdrawal.

You can learn more about this drug on the page for Suboxone Details

I hope this helps!

REPLY

Was this helpful? 0

I need a Dr that excepts medicare as payment. I now am paying for methadone at an outpatient clinic because my insurance...

3 REPLIES

I live in NE WA State and have Interstitial Cystitis and have been dropped by my doctor for no good reason. I have been ...

I need a legit doctor that won't rip me off In the tacoma/Seattle area. Any help is greatly appreciated in advance!?...

1 REPLY

Im 22 years old I have been a addicted to opiates for 6 years. I've lost everything. My fiance, I lost my mom to can...

3 REPLIES

I'm desperate to find a doctor to advocate for me in social security as well my pain. I deal with daily pain aND my ...

3 REPLIES

Trying to find out how to get on pain medication for my back pain how to get a good doctor to trust and help me with wha...

1 REPLY

I have been getting pain meds from my doctor for years now, but he's affiliated with peacehealth and they have made ...

I had just moved to Washington state and in need of a honest pain Doctor who understands the truth about pain for the ba...

1 REPLY

We are in Washington state. My wife has psoriatic arthritis, endometriosis, and fibromyalgia. She was force tapered to 3...

7 REPLIES

I want to move from Maine to NH. I am on SSDI, and have medicaid in Maine, but I don't know if it is given automatic...

3 REPLIES